Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
PARP Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
BMS-986141
/ BMS
stenoparib
(2X-121) / Allarity Therap, Oncoheroes
SC10914
/ Jiangxi Qingfeng Pharma, Shanghai De Novo Pharmatech
M9466
/ EMD Serono
atamparib
(RBN-2397) / Ribon Therap
venadaparib
(NOV 1401) / National OncoVenture, Ildong
INO-1001
/ Roche
NMS-293
/ EMD Serono
amelparib
(JPI-289) / Jeil
nesuparib
(JPI-547) / Jeil
E7016
/ Eisai
TQB3823
/ Sino Biopharm
TSL1502
/ Tasly
AMXI-5001
/ AtlasMedx
AZD9574
/ AstraZeneca
CK-102
/ Fortress
VIO-01
/ Valerio Therap
